Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03284047

Botox for Gummy Smile

Evaluation of Different Doses of Botulinum Toxin Type A for the Treatment of Gummy Smile

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a two part study to measure and observe the efficacy of botulinum toxin A for the treatment of gummy smiles. Part A will randomly compare three different doses of botulinum toxin type A (abobotulinumtoxin A) for the treatment of upper anterior gummy smile with larger gingival exposure (\> 4 mm). Part B will assign one of two doses of botulinum toxin type A for participants with smaller gingival exposure (\< 4 mm). Follow-up visits with photography will occur 4 and 12 weeks after their treatment. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment. This study is a pilot study designed to determine feasibility of this procedure.

Conditions

Interventions

TypeNameDescription
DRUGBotulinum toxin type AParticipants will be randomized to one of three botulinum toxin type A doses.

Timeline

Start date
2019-04-24
Primary completion
2019-04-24
Completion
2019-04-24
First posted
2017-09-15
Last updated
2021-12-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03284047. Inclusion in this directory is not an endorsement.

Botox for Gummy Smile (NCT03284047) · Clinical Trials Directory